Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease

Acta Gastro-Enterologica Belgica

Volumn 72, Issue 3, 2009, Pages 301-305

  Bahari, Ali ^a   Aarabi, Mahmoud ^b   Aarabi, Mohsen ^c   Hedayati, Mehdi ^d   Jarollahi, Ali ^e   Firouzi, Farzad ^b   Aghazadeh, Rahim ^b   Zali, Mohammad Reza ^b   Hashemi, Mohammad ^a,f  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti Saccharomyces cerevisiae antibody; Antineutrophil antibodies; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOFLUORESCENCE; IRAN; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 70449794668     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. QUINTON J.F., SENDID B., REUMAUX D., DUTHILLEUL P., CORTOT A., GRANDBASTIEN B., CHARRIER G., TARGAN S.R., COLOMBEL J.F., POULAIN D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease : prevalence and diagnostic role. Gut, 1998, 42 : 788-791.
2. RUTGEERTS P., VERMEIRE S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology, 1998, 115 : 1006-1009.
3. SEIBOLD F., STICH O., HUFNAGL R., KAMIL S., SCHEURLEN M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease : a family study. Scand. J. Gastroenterol., 2001, 36 : 196-201.
4. VASILIAUSKAS É.A., KAM L.Y., KARP L.C., GAIENNIE J., YANG H., TARGAN S.R. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut, 2000, 47 : 487-496.
5. RUEMMELE F.M., TARGAN S.R., LEVY G., DUBINSKY M., BRAUN J., SEIDMAN E.G. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology, 1998, 115 : 822-829. (Pubitemid 28452928)
6. LENNARD-JONES J.E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol., 1989, 170 (Suppl) : 2-6 ; discussion 16-19.
7. TRUELOVE S.C., WITTS L.J. Cortisone in ulcerative colitis ; final report on a therapeutic trial. Br. Med. J., 1955, 2 (4947) :1041-1048.
8. BEST W.R., BECKTEL J.M., SINGLETON J.W. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology, 1979, 77 : 843-846.
9. SUGI K., SAITOH O., MATSUSE R., TABATA K., UCHIDA K., KOJIMA K., NAKAGAWA K., TANAKA S., TERANISHI T., HIRATA I., KATSU K. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease : prevalence and recognition of putative antigens. Am. J. Gastroenterol., 1999, 94 : 1304-1312.
10. BROEKROELOFS J., MULDER A.H., NELIS G.F., WESTERVELD B.D., TERVAERT J.W., KALLENBERG C.G. Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig. Dis. Sci., 1994, 39 : 545-549.
11. VASILIAUSKAS E.A., PLEVY S.E., LANDERS C.J., BINDER S.W., FERGUSON D.M., YANG H., ROTTER J.I., VIDRICH A., TARGAN S.R. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology, 1996, 110 : 1810-1819.
12. SAIBENI S., FOLLI C., DE FRANCHIS R., BORSI G., VECCHI M. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Dig. Liver Dis., 2003, 35 : 862-868.
13. SHANAHAN F. Inflammatory bowel disease : immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology, 2001, 120 : 622-635. (Pubitemid 32171636)
14. GUPTA S.K., FITZGERALD J.F., CROFFIE J.M., PFEFFERKORN M.D., MOLLESTON J.P., CORKINS M.R. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm. Bowel Dis., 2004, 10 : 240-244.
15. KHAN K., SCHWARZENBERG S.J., SHARP H., GREENWOOD D., WEISDORF-SCHINDELE S. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm. Bowel Dis., 2002, 8 : 325-329.
16. LINSKENS R.K., MALLANT-HENT R.C., GROOTHUISMINK Z.M., BAKKER-JONGES L.E., VAN DE MERWE J.P., HOOIJKAAS H., VON BLOMBERG B.M., MEUWISSEN S.G. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease. pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur. J. Gastroenterol. Hepatol., 2002, 14 : 1013-1018.
17. HALME L., TURUNEN U., HELIO T., PAAVOLA P., WALLE T., MIETTINEN A., JARVINEN H., KONTULA K., FARKKILA M. Familial and sporadic inflammatory bowel disease : comparison of clinical features and serological markers in a genetically homogeneous population. Scand. J. Gastroenterol., 2002, 37 : 692-698.
18. MOORE M.M., FABRICATORIAN D., SELBY W.S. Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease. Intern. Med. J., 2002, 32 : 349-352.
19. KOUTROUBAKIS I.E., PETINAKI E., MOUZAS I.A., VLACHONIKOLIS I.G., ANAGNOSTOPOULOU E., CASTANAS E., MANIATIS A.N., KOUROUMALIS E.A. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am. J. Gastroenterol., 2001, 96 : 449-454.
20. VERMEIRE S., JOOSSENS S., PEETERS M., MONSUUR F., MARIEN G., BOSSUYT X., GROENEN P., VLIETINCK R., RUTGEERTS P. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology, 2001, 120 : 827-833. (Pubitemid 32193179)
21. ANAND V., RUSSELL A.S., TSUYUKI R., FEDORAK R. Perinuclear anti-neutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can. J. Gastroenterol., 2008, 22 : 33-36.
22. MOKROWIECKA A., GASIOROWSKA A., MALECKA-PANAS E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Hepatogastroenterology, 2007, 54 : 1443-1448. (Pubitemid 47203445)
23. MAINARDI E., VILLANACCI V., BASSOTTI G., LISERRE B., ROSSI E., INCARDONA P., FALCHETTI D., TONEGATTI L., MONTANELLI A., BARABINO A., COCCIA C., GAMBINI C. Diagnostic value of serological assays in pediatric inflammatory bowel disorders. Digestion, 2007, 75 : 210-214.
24. AISENBERG J., LEGNANI P.E., NILUBOL N., COBRIN G.M., ELLOZY S.H., HEGAZI R.A., YAGER J., BODIAN C., GORFINE S.R., BAUER J.J., PLEVY S.F., SACHAR D.B. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis ? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol., 2004, 99 : 432-441.
25. SEIBOLD F., WEBER P., KLEIN R., BERG P.A., WIEDMANN K.H. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut, 1992, 33 : 657-662.
26. OUDKERK POOL M., ELLERBROEK P.M., RIDWAN B.U., GOLDSCHMEDING R., VON BLOMBERG B.M., PEÑA A.S., DOLMAN K.M., BRIL H., DEKKER W., NAUTA J.J. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear anti-neutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment Gut, 1993, 34 : 46-50.
27. HERTERVIG E., WIESLANDER J., JOHANSSON C., WIIK A., NILSSON A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand. J. Gastroenterol., 1995, 30 : 693-698.
28. LINDGREN S., FLOREN C.H., LINDHAGEN T., STARCK M., STEWENIUS J., NASSBERGER L. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur. J. Gastroenterol. Hepatol., 1995, 7 : 563-568.
29. FLESHNER P.R., VASILIAUSKAS E.A., KAM L.Y., FLESHNER N.E., GAIENNIE J., ABREU-MARTIN M.T., TARGAN S.R. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut, 2001, 49 : 671-677.
30. SANDBORN W.J., LANDERS C.J., TREMAINE W.J., TARGAN S.R. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis : results of a pilot study. Mayo Clin. Proc., 1996, 71 : 431-436.